GT200000003A - Heterociclos arilimino 2 - substituidos y composiciones que los contienen, para usar como agentes de unionde receptores de progesterona. - Google Patents
Heterociclos arilimino 2 - substituidos y composiciones que los contienen, para usar como agentes de unionde receptores de progesterona.Info
- Publication number
- GT200000003A GT200000003A GT200000003A GT200000003A GT200000003A GT 200000003 A GT200000003 A GT 200000003A GT 200000003 A GT200000003 A GT 200000003A GT 200000003 A GT200000003 A GT 200000003A GT 200000003 A GT200000003 A GT 200000003A
- Authority
- GT
- Guatemala
- Prior art keywords
- arilimino
- progesterone
- heterocicles
- substitutes
- compositions
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960003387 progesterone Drugs 0.000 title 1
- 239000000186 progesterone Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000003998 progesterone receptors Human genes 0.000 abstract 1
- 108090000468 progesterone receptors Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 abstract 1
- 229950001139 timonacic Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23190699A | 1999-01-14 | 1999-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200000003A true GT200000003A (es) | 2001-07-06 |
Family
ID=22871101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200000003A GT200000003A (es) | 1999-01-14 | 2000-01-13 | Heterociclos arilimino 2 - substituidos y composiciones que los contienen, para usar como agentes de unionde receptores de progesterona. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1144396A2 (cs) |
| JP (1) | JP2002534517A (cs) |
| KR (1) | KR20010089831A (cs) |
| CN (1) | CN1337955A (cs) |
| AR (1) | AR022214A1 (cs) |
| AU (1) | AU2708700A (cs) |
| BG (1) | BG105761A (cs) |
| BR (1) | BR9916999A (cs) |
| CA (1) | CA2359562A1 (cs) |
| CO (1) | CO5160338A1 (cs) |
| CZ (1) | CZ20012530A3 (cs) |
| GT (1) | GT200000003A (cs) |
| HU (1) | HUP0105134A2 (cs) |
| ID (1) | ID30514A (cs) |
| IL (1) | IL144031A0 (cs) |
| NO (1) | NO20013318L (cs) |
| SK (1) | SK10032001A3 (cs) |
| SV (1) | SV2002000005A (cs) |
| TR (1) | TR200102041T2 (cs) |
| WO (1) | WO2000042031A2 (cs) |
| ZA (1) | ZA200105253B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8193252B1 (en) | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
| EA007854B1 (ru) * | 1999-08-31 | 2007-02-27 | Шеринг Акциенгезельшафт | Мезопрогестины (модуляторы рецептора прогестерона) в качестве средств лечения и предупреждения доброкачественных зависящих от гормонов гинекологических нарушений |
| HUP0202460A3 (en) * | 1999-08-31 | 2004-04-28 | Schering Ag | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| ATE393150T1 (de) * | 1999-09-14 | 2008-05-15 | Shionogi & Co | 2-imino-1,3-thiazin-derivate |
| JPWO2001072723A1 (ja) * | 2000-03-28 | 2004-01-08 | 日本曹達株式会社 | オキサ（チア）ゾリジン誘導体および抗炎症薬 |
| EP1317456A2 (en) * | 2000-09-07 | 2003-06-11 | Bayer Corporation | Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| CA2440186C (en) * | 2001-03-08 | 2009-01-13 | Shionogi & Co., Ltd. | Medicinal composition containing 1,3-thiazine derivative |
| US7189751B2 (en) | 2001-06-25 | 2007-03-13 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| EP1465882B1 (en) | 2001-12-21 | 2011-08-24 | X-Ceptor Therapeutics, Inc. | Hetrocyclic modulators of nuclear receptors |
| US20060142387A1 (en) * | 2003-06-10 | 2006-06-29 | Rodolfo Cadilla | Chemical compounds |
| CN103382158B (zh) * | 2013-07-29 | 2015-11-18 | 张家港市大伟助剂有限公司 | 一种2-环戊基氨基乙醇的制备方法 |
| BR112022000188A2 (pt) * | 2019-07-10 | 2022-02-22 | Bayer Ag | Método para a preparação de 2-(fenilimino)-1,3-tiazolidin-4-onas |
| CN114507143A (zh) * | 2022-02-26 | 2022-05-17 | 江苏壹药新材料有限公司 | 一种2-乙基-1-氟-4-硝基苯的合成方法 |
| CN114671828B (zh) * | 2022-04-28 | 2024-05-31 | 蔚林新材料科技股份有限公司 | 一种3-甲基-2-噻唑硫酮的制备方法 |
| CN114957288B (zh) * | 2022-06-07 | 2024-02-13 | 苏州华道生物药业股份有限公司 | 一种盐酸四咪唑的合成方法 |
| CN115925559B (zh) * | 2022-11-11 | 2024-12-17 | 上海泰坦科技股份有限公司 | 一种1-氨基-1-环戊基甲醇的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670754A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylimino-oxazolidinen |
| FR1510015A (fr) * | 1966-12-05 | 1968-01-19 | Aquitaine Petrole | Préparation d'imino-thiazolidines |
| DE1767335A1 (de) * | 1968-04-27 | 1971-09-02 | Bayer Ag | Anaesthetikum fuer Tiere |
| DE1963193A1 (de) * | 1969-12-17 | 1971-06-24 | Bayer Ag | N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide |
| FR2117337A5 (en) * | 1970-12-04 | 1972-07-21 | Eastman Kodak Co | Merocyanine dye sensitisers - contg basic and acidic gps for silver halide emulsions |
| US3787575A (en) * | 1970-12-17 | 1974-01-22 | Bayer Ag | N-substituted-2-arylimino-oxazolidines used as acaricides |
| GB1342232A (en) * | 1971-07-29 | 1974-01-03 | Bayer Ag | Aryliminothiazolidines a process for their preparation and their use as acaricides |
| CH614946A5 (cs) * | 1975-05-07 | 1979-12-28 | Ciba Geigy Ag | |
| DE2658138A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | Substituierte 2-phenylimino-thiazolidine, verfahren zu ihrer herstellung sowie ihre verwendung als ektoparasitizide |
| DE2926771A1 (de) * | 1979-07-03 | 1981-01-15 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| DE3049460A1 (de) * | 1980-12-30 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | "thiazolinderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3505432A1 (de) * | 1985-02-16 | 1986-08-21 | Hoechst Ag, 6230 Frankfurt | Pflanzenschutz- und schaedlingsbekaempfungsmittel auf der basis von thiazolidinderivaten sowie neue thiazolidinderivate und verfahren zu ihrer herstellung |
| EP0265162B1 (en) * | 1986-10-17 | 1991-03-06 | Stauffer Chemical Company | Iminooxazolidines, process of preparation and method of use |
| US4806653A (en) * | 1986-10-17 | 1989-02-21 | Stauffer Chemical Company | Process for preparation of iminooxazolidines |
| EP0270138B1 (en) * | 1986-11-04 | 1991-05-29 | Duphar International Research B.V | Substituted 2-phenylimino-oxazolidine compounds having herbicidal activity |
| WO1989004595A2 (en) * | 1987-11-19 | 1989-06-01 | The Upjohn Company | Ectoparasiticides |
-
1999
- 1999-12-14 HU HU0105134A patent/HUP0105134A2/hu unknown
- 1999-12-14 BR BR9916999-1A patent/BR9916999A/pt not_active IP Right Cessation
- 1999-12-14 TR TR2001/02041T patent/TR200102041T2/xx unknown
- 1999-12-14 JP JP2000593599A patent/JP2002534517A/ja active Pending
- 1999-12-14 AU AU27087/00A patent/AU2708700A/en not_active Abandoned
- 1999-12-14 CN CN99816464A patent/CN1337955A/zh active Pending
- 1999-12-14 IL IL14403199A patent/IL144031A0/xx unknown
- 1999-12-14 KR KR1020017008891A patent/KR20010089831A/ko not_active Withdrawn
- 1999-12-14 WO PCT/US1999/029601 patent/WO2000042031A2/en not_active Ceased
- 1999-12-14 ID IDW00200101749A patent/ID30514A/id unknown
- 1999-12-14 CA CA002359562A patent/CA2359562A1/en not_active Abandoned
- 1999-12-14 EP EP99968883A patent/EP1144396A2/en not_active Withdrawn
- 1999-12-14 SK SK1003-2001A patent/SK10032001A3/sk unknown
- 1999-12-14 CZ CZ20012530A patent/CZ20012530A3/cs unknown
-
2000
- 2000-01-06 AR ARP000100044A patent/AR022214A1/es unknown
- 2000-01-13 GT GT200000003A patent/GT200000003A/es unknown
- 2000-01-13 CO CO00001518A patent/CO5160338A1/es unknown
- 2000-01-13 SV SV2000000005A patent/SV2002000005A/es unknown
-
2001
- 2001-06-26 ZA ZA200105253A patent/ZA200105253B/en unknown
- 2001-07-04 NO NO20013318A patent/NO20013318L/no not_active Application Discontinuation
- 2001-08-01 BG BG105761A patent/BG105761A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000042031A2 (en) | 2000-07-20 |
| WO2000042031A3 (en) | 2000-11-09 |
| CA2359562A1 (en) | 2000-07-20 |
| SV2002000005A (es) | 2002-07-16 |
| TR200102041T2 (tr) | 2001-12-21 |
| EP1144396A2 (en) | 2001-10-17 |
| CN1337955A (zh) | 2002-02-27 |
| HUP0105134A2 (hu) | 2002-04-29 |
| CO5160338A1 (es) | 2002-05-30 |
| NO20013318D0 (no) | 2001-07-04 |
| IL144031A0 (en) | 2002-04-21 |
| KR20010089831A (ko) | 2001-10-08 |
| ZA200105253B (en) | 2002-09-05 |
| NO20013318L (no) | 2001-08-30 |
| AU2708700A (en) | 2000-08-01 |
| AR022214A1 (es) | 2002-09-04 |
| BR9916999A (pt) | 2001-10-30 |
| SK10032001A3 (sk) | 2002-05-09 |
| ID30514A (id) | 2001-12-13 |
| BG105761A (en) | 2002-03-29 |
| JP2002534517A (ja) | 2002-10-15 |
| CZ20012530A3 (cs) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200000003A (es) | Heterociclos arilimino 2 - substituidos y composiciones que los contienen, para usar como agentes de unionde receptores de progesterona. | |
| SV2001000004A (es) | Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa | |
| GT199900217A (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios. | |
| CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
| BRPI0411528A (pt) | uso de isomalte como prebiótico | |
| ECSP077236A (es) | Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos | |
| GT200000014A (es) | Derivados de quinolin - 2 - ona sustituidos con heteroarilo utiles como agentes anticancerigenos. | |
| AR028948A1 (es) | Compuestos novedosos | |
| UY26482A1 (es) | Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales | |
| ES2157027T3 (es) | Oxazolidinonas sustituidas y su uso como farmacos antibacterianos. | |
| CR8753A (es) | Derivados de tetraazabenzo [e] azuleno y sus analogos | |
| PA8638801A1 (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| GT199900150A (es) | 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas. | |
| NI200700056A (es) | Nuevos derivados de sulfamidas de heteroaril benzo-fundido útiles como agentes anticonvulsivos | |
| GT200200125A (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
| UY29267A1 (es) | Derivados de piperidina y su uso como agentes antiinflamatorios | |
| HN2005000795A (es) | Pirimidinas como antagonistas del receptor de prostaglandina d2 | |
| CL2008002132A1 (es) | Compuestos derivados de sulfonamidas, moduladores de trpm8; composiciones farmaceuticas que comprenden a dichos compuestos; y uso de dichos compuestos en el tratamiento del dolor neuropatico, dolor inflamatorio, ansiedad, depresion, hiperalgesia inflamatoria, entre otras. | |
| ECSP099563A (es) | Composiciones lubricantes personales complementarias | |
| AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
| CR9507A (es) | Sulfonamidas de diarisulfona y sus usos | |
| SV2004001549A (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| PA8485101A1 (es) | Nuevos antibioticos macrolidos. | |
| UY27894A1 (es) | Derivados de cinamida. | |
| CO2022000700A2 (es) | Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos |